- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07499232
Un estudio de Guselkumab frente a Risankizumab en participantes con enfermedad de Crohn activa de moderada a grave (CHARGE)
Un estudio de fase 3b, multicéntrico, aleatorizado, de etiqueta abierta y controlado activamente para comparar la eficacia y seguridad de Guselkumab frente a Risankizumab en el tratamiento de participantes con enfermedad de Crohn moderadamente a gravemente activa
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- Fase 3
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Study Contact
- Número de teléfono: 844-434-4210
- Correo electrónico: Participate-In-This-Study1@its.jnj.com
Ubicaciones de estudio
-
-
-
Berlin, Alemania, 10825
- Reclutamiento
- GASTRO-Studien
-
Berlin, Alemania, 12203
- Reclutamiento
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF)
-
Erlangen, Alemania, 91054
- Reclutamiento
- Universitatsklinikum Erlangen
-
Grevenbroich, Alemania, 41515
- Reclutamiento
- Praxiszentrum Fur Gastroenterologie und Endoskopie Grevenbroich
-
Jena, Alemania, 07747
- Reclutamiento
- Universitatsklinikum Jena
-
Kiel, Alemania, 24105
- Reclutamiento
- Universitatsklinikum Schleswig Holstein Kiel
-
Ludwigshafen am Rhein, Alemania, 67067
- Reclutamiento
- St. Marien und St. Annastiftskrankenhaus
-
Mannheim, Alemania, 68167
- Reclutamiento
- Universitaetsklinikum Mannheim
-
München, Alemania, 81675
- Reclutamiento
- Klinikum rechts der Isar der TU Munchen
-
-
-
-
-
Graz, Austria, 8036
- Reclutamiento
- LKH-Univ. Klinikum Graz
-
Innsbruck, Austria, 6020
- Reclutamiento
- Medizinische Universitatsklinik Innsbruck
-
Linz, Austria, 4021
- Reclutamiento
- Kepler Universitatsklinikum GmbH
-
Salzburg, Austria, 5020
- Reclutamiento
- LKH - Universitätsklinikum der PMU Salzburg
-
Vienna, Austria, 1090
- Reclutamiento
- Medical University Vienna
-
Vienna, Austria, 1020
- Reclutamiento
- Krankenhaus der Barmherzigen Brüder
-
Wels, Austria, 4600
- Reclutamiento
- Klinikum Wels Grieskirchen
-
Wiener Neustadt, Austria, 2700
- Reclutamiento
- Universitatsklinikum Wiener Neustadt
-
-
-
-
-
Brussels, Bélgica, 1200
- Reclutamiento
- Cliniques Universitaires Saint Luc
-
Brussels, Bélgica, 1070
- Reclutamiento
- ULB Erasme Ziekenhuis
-
Genk, Bélgica, 3600
- Reclutamiento
- Ziekenhuis Oost-Limburg
-
Ghent, Bélgica, 9000
- Reclutamiento
- Ghent University Hospital
-
Leuven, Bélgica, 3000
- Reclutamiento
- Universitair Ziekenhuis Leuven
-
Liège, Bélgica, 4000
- Reclutamiento
- CHU de Liege
-
Roeselare, Bélgica, 8800
- Reclutamiento
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Edmonton, Alberta, Canadá, T5R 1W2
- Reclutamiento
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
British Columbia
-
Vancouver, British Columbia, Canadá, V6Z 2K5
- Reclutamiento
- GIRI Gastrointestinal Research Institute
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8N1Y2
- Reclutamiento
- Charlton Digestive Disease Centre
-
London, Ontario, Canadá, N6K 1M6
- Reclutamiento
- London Digestive Disease Institute
-
Oshawa, Ontario, Canadá, L1J 0C7
- Reclutamiento
- Taunton Surgical Centre
-
Toronto, Ontario, Canadá, M6A 3B4
- Reclutamiento
- Toronto Immune and Digestive Health Institute Inc
-
-
Quebec
-
Montreal, Quebec, Canadá, H3H1E3
- Reclutamiento
- Clinique IMD
-
Montreal, Quebec, Canadá, H2X 0C1
- Reclutamiento
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Brno, Chequia, 62500
- Reclutamiento
- Fakultni nemocnice Brno
-
Brno, Chequia, 636 00
- Reclutamiento
- Vojenska nemocnice Brno
-
Hradec Kralova, Chequia, 500 02
- Reclutamiento
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Králové, Chequia, 500 12
- Reclutamiento
- Hepato-gastroenterologie HK, s.r.o.
-
Ostrava-Poruba, Chequia, 708 00
- Reclutamiento
- Fakultni Nemocnice Ostrava
-
Prague, Chequia, 100 00
- Reclutamiento
- Fakultni nemocnice Kralovske Vinohrady
-
Prague, Chequia, 14000
- Reclutamiento
- Fakultni Thomayerova nemocnice
-
-
-
-
-
Aarhus C, Dinamarca, 8200
- Reclutamiento
- Aarhus University Hospital
-
Esbjerg, Dinamarca, 6700
- Reclutamiento
- Sydvestjysk Sygehus
-
Gistrup, Dinamarca, 9260
- Reclutamiento
- NAU New Aalborg University Hospital
-
Herlev, Dinamarca, 2730
- Reclutamiento
- Herlev Hospital
-
Hilleroed, Dinamarca, 3400
- Reclutamiento
- Nordsjaellands Hospital, Hillerod
-
Hvidovre, Dinamarca, 2650
- Reclutamiento
- Hvidovre Hospital
-
København NV, Dinamarca, 2400
- Reclutamiento
- Bispebjerg Hospital
-
Odense C, Dinamarca, 5000
- Reclutamiento
- Odense UH og Svendberg sygehus
-
-
-
-
-
Banská Bystrica, Eslovaquia, 975 17
- Reclutamiento
- FNsP F. D. Roosevelta Banska Bystrica
-
Bratislava, Eslovaquia, 811 09
- Reclutamiento
- Cliniq s.r.o.
-
Košice, Eslovaquia, 040 13
- Reclutamiento
- ENDOMED s.r.o
-
Nové Zámky, Eslovaquia, 940 34
- Reclutamiento
- Fakultna nemocnica s poliklinikou Nove Zamky
-
Prešov, Eslovaquia, 080 01
- Reclutamiento
- GASTRO I. s.r.o.
-
Prešov, Eslovaquia, 080 01
- Reclutamiento
- Gastro LM s.r.o.
-
Rimavská Sobota, Eslovaquia, 979 12
- Reclutamiento
- Vseobecna nemocnica Rimavska Sobota
-
-
-
-
-
Alicante, España, 03010
- Reclutamiento
- Hosp. Gral. Univ. Dr. Balmis
-
Barcelona, España, 08036
- Reclutamiento
- Hosp. Clinic de Barcelona
-
Ferrol, España, 15405
- Reclutamiento
- Hosp. Arquitecto Marcide
-
Gijón, España, 33394
- Reclutamiento
- Hosp. de Cabuenes
-
Girona, España, 17007
- Reclutamiento
- Hosp. Univ. Dr. Josep Trueta
-
Madrid, España, 28850
- Reclutamiento
- Hosp. Univ. de Torrejon
-
Navarra, España, 31008
- Reclutamiento
- Hosp. de Navarra
-
Santiago de Compostela, España, 15706
- Reclutamiento
- Hosp. Clinico Univ. de Santiago
-
Seville, España, 41009
- Reclutamiento
- Hosp. Virgen Macarena
-
-
-
-
Alabama
-
Dothan, Alabama, Estados Unidos, 36305
- Reclutamiento
- Digestive Health Specialists of the Southeast
-
Mobile, Alabama, Estados Unidos, 36608
- Reclutamiento
- East View Medical Research
-
-
California
-
Anaheim, California, Estados Unidos, 92805
- Reclutamiento
- Clinnova Research
-
Lancaster, California, Estados Unidos, 93534
- Reclutamiento
- Gastro Care Institute
-
Los Alamitos, California, Estados Unidos, 90720
- Reclutamiento
- United Gastroenterologists
-
Los Angeles, California, Estados Unidos, 90048
- Reclutamiento
- TLC Clinical Research Inc
-
Los Angeles, California, Estados Unidos, 90067
- Reclutamiento
- GastroIntestinal Bioscience
-
San Diego, California, Estados Unidos, 92123
- Reclutamiento
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Reclutamiento
- Peak Gastroenterology Associates
-
-
Connecticut
-
Hamden, Connecticut, Estados Unidos, 06518
- Reclutamiento
- Medical Research Center of Connecticut
-
-
Florida
-
Jacksonville, Florida, Estados Unidos, 32258
- Reclutamiento
- Green Leaf Clinical Trials
-
Miami, Florida, Estados Unidos, 33157-6575
- Reclutamiento
- Sanchez Clinical Research, Inc
-
Miami, Florida, Estados Unidos, 33186
- Reclutamiento
- Biodax Medical Research Trials
-
Naples, Florida, Estados Unidos, 34102
- Reclutamiento
- GI Pros Research
-
Orlando, Florida, Estados Unidos, 32806
- Reclutamiento
- Orlando Health Digestive Health Institute
-
Tampa, Florida, Estados Unidos, 33609
- Reclutamiento
- GCP Clinical Research
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30310
- Reclutamiento
- Morehouse School of Medicine
-
Atlanta, Georgia, Estados Unidos, 30342
- Suspendido
- Atlanta Gastroenterology Associates
-
Macon, Georgia, Estados Unidos, 31201
- Reclutamiento
- Gastroenterology Associates of Central GA
-
-
Illinois
-
Northbrook, Illinois, Estados Unidos, 60062
- Reclutamiento
- Comprehensive Gastrointestinal Health Libertyville
-
-
Iowa
-
Clive, Iowa, Estados Unidos, 50325
- Reclutamiento
- Heartland Medical Research Inc
-
-
Kansas
-
Topeka, Kansas, Estados Unidos, 66606
- Reclutamiento
- Cotton-O'Neil Clinical Research Center
-
-
Louisiana
-
Lafayette, Louisiana, Estados Unidos, 70503
- Reclutamiento
- Gastroenterology Clinic of Acadiana
-
Shreveport, Louisiana, Estados Unidos, 71103
- Reclutamiento
- Louisiana State University Health Sciences Center Shreveport
-
-
Maryland
-
Glen Burnie, Maryland, Estados Unidos, 21061
- Reclutamiento
- Woodholme Gastroenterology Associates
-
-
Massachusetts
-
New Bedford, Massachusetts, Estados Unidos, 02740
- Reclutamiento
- Lucida Clinical Trials
-
-
Michigan
-
Farmington Hills, Michigan, Estados Unidos, 48334
- Reclutamiento
- Michigan Center of Medical Research
-
-
New York
-
Carmel, New York, Estados Unidos, 10512
- Reclutamiento
- Westchester Putnam Gastroenterology
-
New York, New York, Estados Unidos, 10028
- Reclutamiento
- New York Gastroenterology Associates
-
New York, New York, Estados Unidos, 10075
- Suspendido
- Lenox Hill Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599 7080
- Reclutamiento
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Estados Unidos, 28207
- Reclutamiento
- Charlotte Gastroenterology and Hepatology, PLLC
-
-
Ohio
-
Mentor, Ohio, Estados Unidos, 44060
- Reclutamiento
- Great Lakes Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73114
- Reclutamiento
- Digestive Disease Specialists Inc
-
-
Pennsylvania
-
Uniontown, Pennsylvania, Estados Unidos, 15401
- Reclutamiento
- Frontier Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, Estados Unidos, 29486
- Reclutamiento
- Palmetto Primary and Specialty Care Physicians, Charleston
-
-
Texas
-
Carrollton, Texas, Estados Unidos, 75010
- Reclutamiento
- DFW Clinical Trials
-
Lubbock, Texas, Estados Unidos, 79424
- Reclutamiento
- Lubbock Gastroenterology
-
San Antonio, Texas, Estados Unidos, 78229
- Reclutamiento
- Gastroenterology Research of America, LLC
-
San Antonio, Texas, Estados Unidos, 78229
- Reclutamiento
- Southern Star Research Institute, LLC
-
Tyler, Texas, Estados Unidos, 75708
- Reclutamiento
- The University of Texas Health Science Center at Tyler
-
-
-
-
-
Amiens, Francia, 80000
- Reclutamiento
- CHU Amiens Picardie
-
Clermont-Ferrand, Francia, 63000
- Reclutamiento
- Clermont Ferrand University Hospital
-
Marseille, Francia, 13015
- Reclutamiento
- Aphm - Hopital Nord
-
Nantes, Francia, 44000
- Reclutamiento
- CHU Nantes - Hotel Dieu
-
Neuilly-sur-Seine, Francia, 92200
- Reclutamiento
- Clinique Ambroise Pare
-
Nîmes, Francia, 30900
- Reclutamiento
- CHU Nimes
-
Paris, Francia, 75018
- Reclutamiento
- APHP - Hopital Bichat - Claude Bernard
-
Paris, Francia, 75012
- Reclutamiento
- Aphp Hopital Saint Antoine
-
Pierre-Bénite, Francia, 69495
- Reclutamiento
- Hospices Civils de Lyon CHU Lyon Sud
-
Reims, Francia, 51100
- Reclutamiento
- CHU de Reims
-
Vandœuvre-lès-Nancy, Francia, 54511
- Reclutamiento
- Centre Hospitalier Universitaire de Nancy - Hôpital Central
-
Échirolles, Francia, 38130
- Reclutamiento
- Institut Prive MICI Clinique des Cedres
-
-
-
-
-
Budapest, Hungría, 1088
- Reclutamiento
- Semmelweis Egyetem
-
Budapest, Hungría, 1036
- Reclutamiento
- Obudai Egeszsegugyi Centrum Kft
-
Budapest, Hungría, H-1136
- Reclutamiento
- Pannónia Magánorvosi Centrum Kft
-
Budapest, Hungría, 1082
- Reclutamiento
- Semmelweis Egyetem 1
-
Budapest, Hungría, 1083
- Reclutamiento
- Semmelweis Egyetem 2
-
Budapest, Hungría, 1139
- Reclutamiento
- Endomedix
-
Gyöngyös, Hungría, 3200
- Reclutamiento
- Clinexpert Gyongyos Kft
-
Szeged, Hungría, 6725
- Reclutamiento
- Szegedi Tudomanyegyetem
-
-
-
-
-
Bologna, Italia, 40138
- Reclutamiento
- A O U Sant Orsola Malpighi
-
Bolzano, Italia, 39100
- Reclutamiento
- Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano
-
Genova, Italia, 16132
- Reclutamiento
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Italia, 20132
- Reclutamiento
- IRCCS Ospedale San Raffaele
-
Roma, Italia, 00168
- Reclutamiento
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Rozzano, Italia, 20089
- Reclutamiento
- Istituto Clinico Humanitas
-
Torino, Italia, 10128
- Reclutamiento
- Ospedale Mauriziano Torino
-
-
-
-
-
Maastricht, Países Bajos, 6229 HX
- Reclutamiento
- Maastricht UMC
-
Nijmegen, Países Bajos, 6525 GA
- Reclutamiento
- Radboud Umcn
-
Tilburg, Países Bajos, 5022 GC
- Reclutamiento
- St. Elisabeth Ziekenhuis
-
-
-
-
-
Bydgoszcz, Polonia, 85 229
- Reclutamiento
- Centrum Medyczne Medis ManerMed Sp Z O O
-
Krakow, Polonia, 30363
- Reclutamiento
- Centrum Medyczne Plejady
-
Krakow, Polonia, 31-513
- Reclutamiento
- Centrum Medyczne Promed
-
Rzeszów, Polonia, 35-326
- Reclutamiento
- Centrum Medyczne 'Medyk' Sp. z o.o. K.
-
Szczecin, Polonia, 71-434
- Reclutamiento
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Polonia, 87 100
- Reclutamiento
- GASTROMED Kopon Zmudzinski i wspolnicy SP j Specjalistyczne Centrum Gastrologii i Endoskopii
-
Warsaw, Polonia, 02-781
- Reclutamiento
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Warsaw, Polonia, 04 501
- Reclutamiento
- Medical Network Sp z o o
-
-
-
-
-
Changzhou, Porcelana, 213018
- Reclutamiento
- Changzhou No 2 Peoples Hospital
-
Chongqing, Porcelana, 400014
- Reclutamiento
- Chongqing General Hospital
-
Fuzhou, Porcelana, 350005
- Reclutamiento
- The First Affiliated Hospital of Fujian Medical University
-
Guangzhou, Porcelana, 510655
- Reclutamiento
- The Sixth Affiliated Hospital Sun Yat sen University
-
Guangzhou, Porcelana, 510261
- Reclutamiento
- The Second Affiliated Hospital of Guangzhou Medical University
-
Nanjing, Porcelana, 210009
- Reclutamiento
- Zhongda Hospital Southeast University
-
Wuhan, Porcelana, 430060
- Reclutamiento
- Renmin Hospital of Wuhan University
-
-
-
-
-
Greater London, Reino Unido, E1 2AJ
- Reclutamiento
- Barts Health NHS Trust
-
Greater London, Reino Unido, NW10 7NS
- Reclutamiento
- London North West University Healthcare NHS Trust
-
Iselworth, Reino Unido, TW7 6AF
- Reclutamiento
- West Middlesex University Hospital
-
London, Reino Unido, NW3 2QG
- Reclutamiento
- Royal Free Hospital
-
London, Reino Unido, W120HS
- Reclutamiento
- Imperial College London
-
London, Reino Unido, NW1 2PG
- Reclutamiento
- University College London Hospitals Nhs Foundation Trust
-
London, Reino Unido, SW10 9NH
- Reclutamiento
- Chelsea And Westminster Hospital
-
Norwich, Reino Unido, NR4 7UQ
- Reclutamiento
- Norfolk and Norwich University Hospital
-
Wolverhampton, Reino Unido, WV10 0QP
- Reclutamiento
- New Cross Hospital
-
-
-
-
-
Linköping, Suecia, 58185
- Reclutamiento
- Linkoping University Hospital
-
Mölndal, Suecia, 431 30
- Reclutamiento
- Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
-
Stockholm, Suecia, 171 76
- Reclutamiento
- Karolinska Universitetssjukhuset
-
Stockholm, Suecia, 116 30
- Reclutamiento
- Ersta sjukhus
-
Stockholm, Suecia, 118 83
- Reclutamiento
- Sodersjukhuset
-
Uppsala, Suecia, 751 85
- Reclutamiento
- Akademiska Sjukhuset
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion criteria:
-
Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
-
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (>=) 220 but less than or equal to (<=) 450
-
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) >= 4 (for participants with isolated ileal disease) or >= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
- a minimum score of 1 for the component of "size of ulcers" AND
- a minimum score of 1 for the component of "ulcerated surface"
-
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
-
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol
Exclusion criteria
- Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
- Currently has or is suspected to have an abscess
- Has an active fistula during screening or at Week 0 with an anticipated need for surgery
- Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
- Currently has a malignancy or has a history of malignancy within 5 years before screening
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Guselkumab
Participants will receive guselkumab induction dose subcutaneously (SC) at Weeks 0, 4, and 8 followed by guselkumab maintenance dose SC once every 4 weeks (q4w) from Week 12 through Week 52. |
Guselkumab will be administered.
Otros nombres:
|
|
Experimental: Risankizumab
Participants will receive risankizumab induction dose intravenously (IV) at Weeks 0, 4, and 8 followed by risankizumab maintenance dose SC once every 8 weeks (q8w) from Week 12 through Week 52. |
Risankizumab will be administered. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of Participants with Deep Remission at Week 52
Periodo de tiempo: At Week 52
|
Deep remission is a composite endpoint defined as achieving both clinical remission and endoscopic remission at the participant level. Clinical remission is defined as Crohn's Disease Activity Index (CDAI) score less than (<) 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic remission is defined as Simple Endoscopic Score for Crohn's Disease (SES-CD) less than or equal to (<=) 4 with at least a 2-point reduction from baseline and no sub score greater than (>) 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Composite Endpoint of Number of Participants with Clinical Remission and Endoscopic Response at Week 52
Periodo de tiempo: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic response is defined as >50 percent (%) improvement from baseline in the SES CD or SES-CD score <= 2 or a decrease of at least 2 points in participants with a baseline score of 4 and isolated ileal disease. This is a composite endpoint defined to measure achievement of both clinical remission and endoscopic response. |
At Week 52
|
|
Number of Participants with Endoscopic Remission at Week 52
Periodo de tiempo: At Week 52
|
Endoscopic remission is defined as SES-CD <= 4 with at least a 2-point reduction from baseline and no sub score > 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
|
Number of Participants with Clinical Remission at Week 52
Periodo de tiempo: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. |
At Week 52
|
|
Number of Participants with Steroid-Free Clinical Remission at Week 52
Periodo de tiempo: At Week 52
|
Steroid-free clinical remission is defined as clinical remission at Week 52 and not receiving corticosteroids for at least 90 days prior to Week 52. Clinical remission is defined as CDAI score < 150-point. |
At Week 52
|
|
Number of Participants with Abnormalities in Laboratory Parameters
Periodo de tiempo: Up to Week 148
|
Number of participants with abnormalities in laboratory parameters (hematology and chemistry) will be reported. |
Up to Week 148
|
|
Number of Participants With Change From Baseline in Laboratory Abnormalities
Periodo de tiempo: Up to week 148
|
Number of participants with change from baseline in laboratory abnormalities (hematology and chemistry) will be reported. |
Up to week 148
|
|
Number of Participants with Adverse Events (AEs), Serious AEs and AEs Leading to Discontinuation of Study Intervention
Periodo de tiempo: Up to Week 165
|
An AE is any untoward medical occurrence in a participant administered a pharmaceutical (investigational or non investigational) product. An AE does not necessarily have a causal relationship with the treatment. An SAE is any untoward medical occurrence that at any dose results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product and is medically important. |
Up to Week 165
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CNTO1959CRD3009
- CNTO1959CRD3009 (Otro identificador: Janssen Research & Development, LLC)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
The data sharing policy of Johnson & Johnson Innovative Medicine is available at www.innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .